HUMANA, INC. for HUMANA INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax Reform Implementation Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| VERONICA JACKSON | — |
| JEFFREY LUNGREN | — |
| RACHEL MAGNUSON | — |
Pharmacy PHA
Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Prescription Drug Rebate Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| VERONICA JACKSON | — |
| JEFFREY LUNGREN | — |
| RACHEL MAGNUSON | — |
Health Issues HCR
Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 CMS-0057-P Interoperability and Prior Authorization Proposed Rule Clinical Policy Issues Including Workforce and Mental Health Employer Group Coverage Policy Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| VERONICA JACKSON | — |
| JEFFREY LUNGREN | — |
| RACHEL MAGNUSON | — |
Medicare/Medicaid MMM
Medicare Advantage (MA) Policy and Reimbursement Announcement of Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) Medicare Part D Issues Medicaid Policy Issues Including Redeterminations and Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Prescription Drug Rebate Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act (117th Congress) Prior Authorization Policy and Regulatory Issues Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (RIN 0955-AA03) CMS Guidance on Direct Negotiation (Official Title: Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2026, and Solicitation of Comments) CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health CY 2024 Home Health Prospective Payment System Proposed Rule (CMS-1780-P) FY 2024 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Proposed Rule (CMS-1785-P) CY 2024 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS 1786-P) CY 2024 Medicare Physician Fee Schedule Proposed Rule (CMS-1784-P) Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Proposed Rule (CMS 1793-P) H.R. 4822, Health Care Price Transparency Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| VERONICA JACKSON | — |
| JEFFREY LUNGREN | — |
| RACHEL MAGNUSON | — |
Defense DEF
TRICARE Policy Issues including Telehealth and Value-Based Care NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues H.R. 2670, National Defense Authorization Act for Fiscal Year 2024 S. 2226, National Defense Authorization Act for Fiscal Year 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| VERONICA JACKSON | — |
| JEFFREY LUNGREN | — |
| RACHEL MAGNUSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.